Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol in Myelodysplastic Syndromes
NCT00064376Phase 2Completed
- Sponsor
- Cedars-Sinai Medical Center
- Start
- May 2003
- Primary completion
- Nov 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of paricalcitol in myelodysplastic syndrome (MDS), sponsored by Cedars-Sinai Medical Center. Started May 2003; status: completed.
02
Drugs
paricalcitol
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00064376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00064376.